Gene expression profiling of diffuse large B-cell lymphoma supervised by CD21 expression

British Journal of Haematology

Volumn 142, Issue 4, 2008, Pages 562-570

  Miyazaki, Kana ^a   Yamaguchi, Motoko ^a   Suguro, Miyuki ^a   Choi, Woonyoung ^b   Ji, Yuan ^b   Xiao, Lianchun ^b   Zhang, Wei ^b   Ogawa, Shoko ^a   Katayama, Naoyuki ^a   Shiku, Hiroshi ^a   Kobayashi, Tohru ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CD21; Diffuse large B cell lymphoma; Gene expression profiling; Gene Ontology; Immunoglobulin M

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IGHM GENE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MACHINE; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; RECEPTORS, COMPLEMENT 3D; TUMOR MARKERS, BIOLOGICAL;

EID: 47649105857     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07218.x     Document Type: Article

References (25)

1. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, J., Jr., Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Levy, R., Wilson, W., Grever, M.R., Byrd, J.C., Botstein, D., Brown, P.O. Staudt, L.M. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503 511.
2. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T., Harris, M.A., Hill, D.P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J.C., Richardson, J.E., Ringwald, M., Rubin, G.M. Sherlock, G. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature Genetics, 25, 25 29.
3. Banham, A.H., Connors, J.M., Brown, P.J., Cordell, J.L., Ott, G., Sreenivasan, G., Farinha, P., Horsman, D.E. Gascoyne, R.D. (2005) Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clinical Cancer Research, 11, 1065 1072.
4. Barrans, S.L., Fenton, J.A., Banham, A., Owen, R.G. Jack, A.S. (2004) Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome. Blood, 104, 2933 2935.
5. Fearon, D.T. Carroll, M.C. (2000) Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annual Review of Immunology, 18, 393 422.
6. Hans, C.P., Weisenburger, D.D., Greiner, T.C., Gascoyne, R.D., Delabie, J., Ott, G., Muller-Hermelink, H.K., Campo, E., Braziel, R.M., Jaffe, E.S., Pan, Z., Farinha, P., Smith, L.M., Falini, B., Banham, A.H., Rosenwald, A., Staudt, L.M., Connors, J.M., Armitage, J.O. Chan, W.C. (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 103, 275 282.
7. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H., Poleri, S.A., Piris, M.A., Ralfkiaer, E. Warnke, R.A. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361 1392.
8. Ichikawa, A., Kinoshita, T., Watanabe, T., Kato, H., Nagai, H., Tsushita, K., Saito, H. Hotta, T. (1997) Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. New England Journal of Medicine, 337, 529 534.
9. Jaffe, E.S., Harris, N.L., Stein, H. Vardiman, J.W. (2001) Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, World Health Organization Classification of Tumours. IARC Press, Lyon, France.
10. Lossos, I.S. Morgensztern, D. (2006) Prognostic biomarkers in diffuse large B-cell lymphoma. Journal of Clinical Oncology, 24, 995 1007.
11. Lossos, I.S., Alizadeh, A.A., Eisen, M.B., Chan, W.C., Brown, P.O., Botstein, D., Staudt, L.M. Levy, R. (2000) Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America, 97, 10209 10213.
12. Lossos, I.S., Jones, C.D., Warnke, R., Natkunam, Y., Kaizer, H., Zehnder, J.L., Tibshirani, R. Levy, R. (2001) Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood, 98, 945 951.
13. Monti, S., Savage, K.J., Kutok, J.L., Feuerhake, F., Kurtin, P., Mihm, M., Wu, B., Pasqualucci, L., Neuberg, D., Aguiar, R.C., Dal Cin, P., Ladd, C., Pinkus, G.S., Salles, G., Harris, N.L., Dalla-Favera, R., Habermann, T.M., Aster, J.C., Golub, T.R. Shipp, M.A. (2005) Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood, 105, 1851 1861.
14. Ogawa, S., Yamaguchi, M., Oka, K., Taniguchi, M., Ito, M., Nishii, K., Nakase, K., Ohno, T., Kita, K., Kobayashi, T. Shiku, H. (2004) CD21S antigen expression in tumour cells of diffuse large B-cell lymphomas is an independent prognostic factor indicating better overall survival. British Journal of Haematology, 125, 180 186.
15. Oka, K., Ohno, T., Kita, K., Yamaguchi, M., Takakura, N., Nishii, K., Miwa, H. Shirakawa, S. (1994) PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma. British Journal of Haematology, 86, 786 791.
16. Otsuka, M., Yakushijin, Y., Hamada, M., Hato, T., Yasukawa, M. Fujita, S. (2004) Role of CD21 antigen in diffuse large B-cell lymphoma and its clinical significance. British Journal of Haematology, 127, 416 424.
17. Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, R.I., Gascoyne, R.D., Muller-Hermelink, H.K., Smeland, E.B., Giltnane, J.M., Hurt, E.M., Zhao, H., Averett, L., Yang, L., Wilson, W.H., Jaffe, E.S., Simon, R., Klausner, R.D., Powell, J., Duffey, P.L., Longo, D.L., Greiner, T.C., Weisenburger, D.D., Sanger, W.G., Dave, B.J., Lynch, J.C., Vose, J., Armitage, J.O., Montserrat, E., Lopez-Guillermo, A., Grogan, T.M., Miller, T.P., LeBlanc, M., Ott, G., Kvaloy, S., Delabie, J., Holte, H., Krajci, P., Stokke, T. Staudt, L.M. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. New England Journal of Medicine, 346, 1937 1947.
18. Roberts, R.A., Rimsza, L.M., Staudt, L., Rosenwald, A., Chan, W., Dave, S., Gascoyne, R.D., Connors, J.M., Smeland, E.B., Muller-Hermelink, H.K., Campo, E., Jaffe, E.S., Wilson, W., Tan, B.K., Fisher, R.I., Grogan, T.M. Miller, T.P 2006) Gene expression differences between low and high stage diffuse large B cell lymphoma (DLBCL). Blood, 108, 243A (Abstract no. 809).
19. Shipp, M.A., Ross, K.N., Tamayo, P., Weng, A.P., Kutok, J.L., Aguiar, R.C., Gaasenbeek, M., Angelo, M., Reich, M., Pinkus, G.S., Ray, T.S., Koval, M.A., Last, K.W., Norton, A., Lister, T.A., Mesirov, J., Neuberg, D.S., Lander, E.S., Aster, J.C. Golub, T.R. (2002) Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nature Medicine, 8, 68 74.
20. Tedder, T.F., Clement, L.T. Cooper, M.D. (1984) Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. Journal of Immunology, 133, 678 683.
21. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. New England Journal of Medicine, 329, 987 994.
22. Timens, W., Boes, A. Poppema, S. (1989) Human marginal zone B cells are not an activated B cell subset: strong expression of CD21 as a putative mediator for rapid B cell activation. European Journal of Immunology, 19, 2163 2166.
23. Wright, G., Tan, B., Rosenwald, A., Hurt, E.H., Wiestner, A. Staudt, L.M. (2003) A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 100, 9991 9996.
24. Yamaguchi, M., Seto, M., Okamoto, M., Ichinohasama, R., Nakamura, N., Yoshino, T., Suzumiya, J., Murase, T., Miura, I., Akasaka, T., Tamaru, J., Suzuki, R., Kagami, Y., Hirano, M., Morishima, Y., Ueda, R., Shiku, H. Nakamura, S. (2002) De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood, 99, 815 821.
25. Zhang, B., Schmoyer, D., Kirov, S. Snoddy, J. (2004) GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics, 5, 16.